The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PG2 injection, a novel botanical drug approved for improving cancer-related fatigue among advanced cancer patients under standard palliative care: A double blind, multi-center, randomized phase IV study.
 
Cheng-Hsu Wang
Research Funding - PharmaEngine
 
Yuen-Liang Lai
No Relationships to Disclose
 
Cheng-Yao Lin
No Relationships to Disclose
 
Jen-Shi Chen
Research Funding - Daiichi Sankyo; Lilly; MedImmune; MSD Oncology; Ono Pharmaceutical; orient EuroPharma; TTY Biopharm
 
Ching-Liang Ho
No Relationships to Disclose
 
Kun-Ming Rau
No Relationships to Disclose
 
Jo-Ting Tsai
Research Funding - Shanghai Biochip
 
Cheng-Shyong Chang
Honoraria - Celgene; Janssen; Kirin Pharmaceuticals; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Celgene; Janssen; Novartis; Roche; Takeda
Speakers' Bureau - Celgene; Janssen; Lilly; MSD; Novartis; PhytoHealth; Roche
 
Su-Peng Yeh
No Relationships to Disclose